Botulinum neurotoxin A (BoNT-A) is a treatment used to decrease spasticity. It is delivered as an injection.
Collison L (2020) Spastic Diplegia–Bilateral Cerebral Palsy. St Paul: Gillette Children’s Specialty Press.
The mission of the Cerebral Palsy Research Network (CPRN) is to improve outcomes that people with cerebral palsy value most through high quality clinical research and quality initiatives.